The main objective of this study is to determine the rate of healthy surgical margins after tumor resection in transoral robot-assisted surgery for glottic and/or supraglottic early stage (T1-T2) laryngeal cancer.

Inclusion Criteria:

• The subject has signed consent
• The subject must be a member or beneficiary of a health insurance plan
• The patient is available for 12 months of follow-up
• The subject has a cancer of the larynx:
• classified T1 or T2 in the TNM
• glottic localization and / or supraglottic regardless of node status
• with or without a history of head and neck cancer
• The subject does not have distant metastasis (M0)
• A decision for endoscopic robot-assisted surgery is retained in multidisciplinary meeting

Exclusion Criteria:

-

This study is aimed at all patients with early stage (T1 or T2) glottic and / or supraglottic squamous cell carcinoma of the larynx, whatever their status and cervical lymph nodes without distant metastases (M0) and for whom endoscopic surgical treatment with robotic assistance is indicated following a multidisciplinary meeting.